HF Advisory Group LLC Sells 4,151 Shares of Cardinal Health, Inc. (NYSE:CAH)

HF Advisory Group LLC lessened its stake in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 48.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,446 shares of the company's stock after selling 4,151 shares during the quarter. HF Advisory Group LLC's holdings in Cardinal Health were worth $526,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the company. Paragon Capital Management Inc. lifted its stake in shares of Cardinal Health by 0.7% in the second quarter. Paragon Capital Management Inc. now owns 14,758 shares of the company's stock valued at $1,451,000 after buying an additional 99 shares in the last quarter. Huntington National Bank raised its holdings in shares of Cardinal Health by 0.9% in the 3rd quarter. Huntington National Bank now owns 10,792 shares of the company's stock worth $1,193,000 after acquiring an additional 100 shares during the last quarter. Blair William & Co. IL lifted its position in Cardinal Health by 0.9% in the 2nd quarter. Blair William & Co. IL now owns 11,442 shares of the company's stock valued at $1,125,000 after acquiring an additional 103 shares in the last quarter. Frazier Financial Advisors LLC boosted its stake in Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock valued at $28,000 after purchasing an additional 104 shares during the last quarter. Finally, UMB Bank n.a. increased its holdings in Cardinal Health by 4.9% during the 3rd quarter. UMB Bank n.a. now owns 2,249 shares of the company's stock worth $249,000 after purchasing an additional 106 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on CAH shares. Bank of America raised Cardinal Health from a "neutral" rating to a "buy" rating and lifted their target price for the company from $132.00 to $145.00 in a research report on Monday, January 6th. Citigroup lifted their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the stock a "neutral" rating in a report on Friday, January 10th. Deutsche Bank Aktiengesellschaft raised their price target on shares of Cardinal Health from $119.00 to $124.00 and gave the company a "hold" rating in a research report on Monday, November 4th. UBS Group upped their price objective on shares of Cardinal Health from $134.00 to $139.00 and gave the stock a "buy" rating in a research report on Monday, November 4th. Finally, Barclays lifted their target price on shares of Cardinal Health from $117.00 to $133.00 and gave the stock an "overweight" rating in a research report on Monday, November 4th. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $133.29.

Cardinal Health Price Performance

CAH stock traded down $0.76 during trading on Friday, reaching $126.27. The company had a trading volume of 1,642,944 shares, compared to its average volume of 1,877,583. The company has a market cap of $30.56 billion, a P/E ratio of 24.57, a PEG ratio of 1.48 and a beta of 0.63. The business has a 50 day moving average of $120.75 and a 200 day moving average of $112.03. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $127.27.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.26. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The company had revenue of $52.28 billion during the quarter, compared to analyst estimates of $50.90 billion. During the same quarter last year, the company earned $1.73 EPS. The firm's revenue for the quarter was down 4.3% on a year-over-year basis. Research analysts expect that Cardinal Health, Inc. will post 7.82 earnings per share for the current year.

Cardinal Health Cuts Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd were issued a $0.5056 dividend. The ex-dividend date of this dividend was Thursday, January 2nd. This represents a $2.02 annualized dividend and a yield of 1.60%. Cardinal Health's dividend payout ratio (DPR) is presently 39.30%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.